Department of Urology, Hunan Children's Hospital, Changsha 410007, China.
Institute of Biomineralization and Lithiasis Research, Jinan University, Guangzhou 510632, China.
Oxid Med Cell Longev. 2020 Jan 6;2020:1817635. doi: 10.1155/2020/1817635. eCollection 2020.
Crystal adhesion is an important link in the formation of kidney stones. This study investigated and compared the adhesion differences between nano-calcium oxalate monohydrate (COM) and human renal proximal tubule epithelial (HK-2) cells before and after treatment with tea polysaccharides (TPSs) TPS0, TPS1, TPS2, and TPS3 with molecular weights of 10.88, 8.16, 4.82, and 2.31 kDa, respectively. TPS treatment effectively reduced the damage of COM to HK-2 cells, thereby resulting in increased cell activity, decreased release of lactate dehydrogenase, cell morphology recovery, decreased level of reactive oxygen species, increased mitochondrial membrane potential, increased lysosomal integrity, decreased expression of adhesion molecule osteopontin and eversion of phosphatidylserine, and decreased crystal adhesion. Among the TPSs, TPS2 with moderate molecular weight had the best protective effect on cells and the strongest effect on the inhibition of crystal adhesion. Thus, TPS2 may be a potential anticalculus drug.
晶体黏附是肾结石形成的重要环节。本研究探讨并比较了纳米草酸钙一水合物(COM)与经茶多糖(TPS)TPS0、TPS1、TPS2 和 TPS3 处理前后与人肾近端小管上皮(HK-2)细胞黏附差异,其中 TPS0、TPS1、TPS2 和 TPS3 的分子量分别为 10.88、8.16、4.82 和 2.31 kDa。TPS 处理可有效减轻 COM 对 HK-2 细胞的损伤,从而提高细胞活性,降低乳酸脱氢酶释放量,恢复细胞形态,降低活性氧水平,增加线粒体膜电位,维持溶酶体完整性,降低黏附分子骨桥蛋白表达,翻转磷脂酰丝氨酸,减少晶体黏附。在 TPS 中,分子量适中的 TPS2 对细胞具有最佳的保护作用,对抑制晶体黏附的作用最强。因此,TPS2 可能是一种有潜力的抗结石药物。